Can we increase survival in breast cancer with innovative applications of conventional drugs?
Swain
S M
SM
Lombardi Cancer Centre, Georgetown University, Washington, DC.
Harris
L N
LN
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality*; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D009362:Neoplasm Metastasis; D015996:Survival Rate
D004317:Doxorubicin; D005472:Fluorouracil